Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction of NVP-1805-R1 and NVP-1805-R2 in Healthy Volunteers
NCT03802526Phase 1Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Apr 2019
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan, rosuvastatin and ezetimibe in hypertension (HTN) and dyslipidemia (3 arms), sponsored by NVP Healthcare Co., Ltd. Primary endpoint: Pharmacokinetic interaction. Started Apr 2019; status: completed.
02
Drugs
telmisartanrosuvastatinezetimibe
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT03802526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802526.